Kristofor K Ellestad - Department of Medicine (Neurology),, University of Alberta

基本信息

浏览量：6

职业迁徙

个人简介

Kristofor K Ellestad currently works at the Department of Microbiology, Immunology and Infectious Diseases, The University of Calgary. Kristofor does research in Immunology with a particular focus on development of chimeric antigen receptor T-cell (CAR-T) cancer immunotherapies, and also has a longstanding interest in understanding the control of immune tolerance and the development of clinically translatable therapeutic modalities to induce tolerance.

研究兴趣

论文共 41 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A bivalent COVID-19 mRNA vaccine, PTX-COVID19-M1.2, elicited broad immune responses and protected animals from SARS-CoV-2 Omicron subvariants infection

Jun Liu,Li Wang,Alexandra Kurtesi,Patrick Budylowski,Kyle Potts, Haritha Menon, Yilin Tan,Philip Samaan, Xinan Liu, Yisen Wang,Queenie Hu,Reuben Samson,Freda Qi,Danyel Evseev,Cini John,Kristofor Ellestad, Yue Fan, Frans Budiman, Ellaine Tohan, Jennifer Yang,Eric Marcusson,Anne-Claude Gingras,Douglas Mahoney,Mario Ostrowski, Natalia Orozco

crossref（2024）

引用0浏览0引用

Abstract 5002: Next-generation Mrna-Lnp Vaccine Prototype Achieves Tumor Clearance in a GBM Mouse Model

Robert Nechanitzky, Snelling,Kristofor Ellestad,Xueqing Lun, Kirstin Olsen, Yu Wu, Yury Karpov, Jun Liu,Matthew Gold, Haritha Menon, Rajesh Krishnan, Robert Georgantas, Pamela S. Ohashi,Douglas J. Mahoney,Jennifer A. Chan,Natalia Martin-Orozco

Cancer Researchno. 6_Supplement (2024): 5002-5002

引用0浏览0引用

Internal Regulation Between Constitutively Expressed T Cell Coinhibitory Receptors BTLA and CD5 and Tolerance in Recent Thymic Emigrants